Polisan to invest 3.5 billion rubles in new production in St. Petersburg

The Russian pharmaceutical company Polisan is investing 3.5 billion rubles in a project to establish production facilities within the Sofiysky industrial park in the Pushkinsky district of St. Petersburg. The company plans to create 150 jobs within five years, including 120 highly productive ones.
The company will construct a modern licensed distribution complex with 10,000 pallet spaces and a production site on an 11.5-hectare land. The specific types of drugs that Polisan will produce at this plant have not been specified.
Polisan currently owns a pharmaceutical facility in St. Petersburg, as well as a plant dedicated to the production of active pharmaceutical ingredients in Belgorod. These enterprises produce four original drugs.